Aridis Pharmaceuticals Inc (NASDAQ:ARDS)
| 0.2811 Delayed Data As of Jun 01 |  -0.1126 / -28.33%Today’s Change | 0.15 Today|||52-Week Range 2.77 | -76.18% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 2.9M | 22.3M | 25.1M | 24.2M | |
| Short Term Investment Cash | -738.0K | 19.4M | 2.8M | -859.0K | ||
| Cash & Short Term Investments | 2.9M | 22.3M | 25.1M | 24.2M | ||
| Receivables | Receivables | 522.0K | 67.0K | 0.00 | 1.7M | |
| Inventories | Inventories | -- | -- | -- | 0.00 | -- |
| Current Assets | Other Current Assets | 153.0K | 51.0K | 244.0K | 2.5M | |
| Current Assets | 3.6M | 22.4M | 25.3M | 28.3M | ||
| Total Assets | Property, Plant and Equipment - Gross | 182.0K | 197.0K | 965.0K | 1.8M | |
| Depreciation | -140.0K | -158.0K | -215.0K | -491.0K | ||
| Intangible Assets | 54.0K | 48.0K | 43.0K | 38.0K | ||
| Other Assets | 275.0K | 89.0K | 388.0K | 1.0M | ||
| Total Assets | 3.9M | 22.5M | 26.5M | 31.6M | ||
| Liabilities | Accounts Payable | 402.0K | 678.0K | 933.0K | 2.3M | |
| Short Term Debt | 3.7M | 0.00 | 0.00 | 0.00 | ||
| Accrued Expenses | 1.2M | 1.2M | 1.9M | 2.7M | ||
| Other Current Liabilities | 1.3M | 1.2M | 2.0M | 2.7M | ||
| Other Liabilities | 5.9M | 2.4M | 3.2M | 5.3M | ||
| Total Liabilities | Other Liabilities | 0.00 | 6.4M | 11.9M | 0.00 | |
| Total Liabilities | 5.9M | 8.8M | 15.0M | 5.3M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 25.9M | 58.9M | 74.2M | 0.00 | ||
| Common Equity | -27.9M | -45.1M | -62.8M | 26.3M | ||
| Total Shareholder Equity | -2.0M | 13.8M | 11.4M | 26.3M | ||
| Share Information | Common Shares Outstanding | 8.2M | 8.2M | 8.2M | 8.1M | |
| Addtl. Info. | No data currently available for this section. | |||||
